Abivax (ABVX) Retained Earnings (2022 - 2025)
Historic Retained Earnings for Abivax (ABVX) over the last 4 years, with Q3 2025 value amounting to -$485.9 million.
- Abivax's Retained Earnings changed N/A to -$485.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$485.9 million, marking a year-over-year change of. This contributed to the annual value of -$280.7 million for FY2024, which is 7561.32% down from last year.
- According to the latest figures from Q3 2025, Abivax's Retained Earnings is -$485.9 million.
- In the past 5 years, Abivax's Retained Earnings registered a high of -$84.4 million during Q4 2022, and its lowest value of -$485.9 million during Q3 2025.
- Over the past 4 years, Abivax's median Retained Earnings value was -$292.3 million (recorded in 2024), while the average stood at -$320.5 million.
- Its Retained Earnings has fluctuated over the past 5 years, first crashed by 8823.82% in 2023, then crashed by 6565.71% in 2025.
- Over the past 4 years, Abivax's Retained Earnings (Quarter) stood at -$84.4 million in 2022, then plummeted by 88.24% to -$159.0 million in 2023, then crashed by 76.56% to -$280.7 million in 2024, then plummeted by 73.15% to -$485.9 million in 2025.
- Its Retained Earnings stands at -$485.9 million for Q3 2025, versus -$484.3 million for Q2 2025 and -$456.7 million for Q1 2025.